KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Equity (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Return on Equity for 10 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 4.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 4.0% year-over-year, with the annual reading at 0.0% for FY2025, 4.0% up from the prior year.
  • Return on Equity hit 0.0% in Q4 2025 for Fulgent Genetics, up from 0.04% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.61% in Q1 2021 to a low of 0.14% in Q1 2024.
  • Historically, Return on Equity has averaged 0.12% across 5 years, with a median of 0.03% in 2023.
  • Biggest five-year swings in Return on Equity: surged 61bps in 2021 and later plummeted -39bps in 2023.
  • Year by year, Return on Equity stood at 0.45% in 2021, then crashed by -76bps to 0.11% in 2022, then crashed by -223bps to 0.14% in 2023, then surged by 73bps to 0.04% in 2024, then soared by 100bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for FLGT at 0.0% in Q4 2025, 0.04% in Q3 2025, and 0.05% in Q2 2025.